BDI MONTHLY UPDATES
What's New in March 2026?
Do you ever feel stumped when someone in your care is reluctant to take needed medication, appears to be too overwhelmed to take action, or perhaps seems not interested in diabetes management?
On April 18, BDI will host a live, one-day, 6-hour CME workshop: Engaging the Disengaged: Innovative Strategies for Promoting Behavior Change in Diabetes. Join Dr. Polonsky (BDI President) and Dr. Guzman (BDI Director of Clinical Education) for this lively interactive workshop which will examine the powerful role of psychosocial factors in diabetes self-management. Participants will deepen their skills in recognizing and addressing common barriers to effective self-management and cardiometabolic medication initiation and maintenance, while fostering engaging, respectful, stigma-free clinical encounters.
Registration includes lunch and refreshments and will be limited to 50 participants, and we expect it will fill quickly! Click here to find out more.
And, many thanks to Abbott Diabetes Care for supporting this program.
BDI staff served as co-authors on two new publications this month:
Insulin Pen Needle Reuse in U.S. Adults with Diabetes: A Cross‑Sectional Survey Study on Patterns, Motivations, and Educational Implications
Follow us on Facebook and stay in the know about all happenings at BDI
JOIN US FOR A LOCAL EVENT
Monthly Events
BEHAVIORAL DIABETES INSTITUTE
Recent Publications
During 2024, BDI staff authored or co-authored 24 scientific publications (which includes the 3 new ones highlighted above) and 8 published abstracts at major scientific meetings. You can see the full list right HERE. Our work has covered a wide range, including studies on diabetes distress, the value of continuous glucose monitoring (CGM) for people with diabetes, the impact of diabetes medications on quality of life, the benefits of diabetes technology for people with type 1 and type 2 diabetes, diabetes stigma, and more.
Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial Interviews
William H Polonsky 1 2, Emma L Low 3, Carla Dias-Barbosa 4, Amy Clark 3, Karen Bailey 3, Liza Ilag 5, Livia Firmino Gonçalves 5, Rebecca Threlkeld 5, Christopher J Child 5, Michael B Davidson 5, Eden Miller 6, Felicia T Gelsey 5 Abstract
Quality of Life and Humanistic Burden of Adults with Type 1 Diabetes with Recurrent Severe Hypoglycemic Events and Impaired Awareness of Hypoglycemia Using a Continuous Glucose Monitor
Adriana Boateng-Kuffour 1, Caitlin S Kelly 2, Huyen T Nguyen 2, Nanxin Li 3, Keval Chandarana 3, Katherine S Chapman 2, Liang Chen 3, Emilee M Cornelius 2, Wendy A Wolf 2, Beth Barber 3, William H Polonsky 4 Abstract Introduction: This